Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 2/20 | 0.31 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.30 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27445356 | 0.99 | HPSE (0.33) | PDE10AHPSEPRKDCMAPK14 | |
| SCHEMBL27445374 | 0.99 | HPSE (0.33) | PDE10AHPSEPRKDCMAPK14 | |
| SCHEMBL27445372 | 0.99 | HPSE (0.33) | PDE10AHPSEPRKDCMAPK14 | |
| SCHEMBL27445353 | 0.99 | PDE10A (0.34) | PDE10AHPSEPRKDCMAPK14KDM4E | |
| SCHEMBL27445377 | 0.98 | HPSE (0.34) | PDE10AHPSEPRKDCMAPK14KDM4E | |
| SCHEMBL27445363 | 0.98 | PDE10A (0.34) | PDE10AHPSEPRKDCMAPK14KDM4E | |
| SCHEMBL27445370 | 0.97 | PDE10A (0.34) | PDE10AHPSEPRKDCMAPK14KDM4E | |
| SCHEMBL27445375 | 0.97 | PDE10A (0.34) | PDE10AHPSEPRKDCMAPK14KDM4E | |
| SCHEMBL27445343 | 0.97 | KDM4E (0.33) | HPSEPRKDCMAPK14KDM4EATM | |
| SCHEMBL27445379 | 0.97 | PDE10A (0.34) | PDE10AHPSEPRKDCMAPK14KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030894-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| US-12030894-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030894-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | OR10J3, OCIAD2, OCIAD1 | PDE10A 1752/4885HPSE 3724/4885PRKDC 2791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.